Education
About Us
Working with TipRanks
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
Total Valuation
AxoGen has a market cap or net worth of $791.42M. The enterprise value is $552.86M.
Market Cap$791.42M
Enterprise Value$552.86M
Share Statistics
AxoGen has 46,012,573 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,012,573
Owned by Insiders1.82%
Owned by Institutions37.38%
Financial Efficiency
AxoGen’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -1.88%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-1.88%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee415.38K
Profits Per Employee-22.09K
Employee Count451
Asset Turnover0.92
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of AxoGen is ―. AxoGen’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value7.02
Price to FCF―
Price to Operating Cash Flow99.69
PEG Ratio―
Income Statement
In the last 12 months, AxoGen had revenue of 187.34M and earned -9.96M in profits. Earnings per share was -0.23.
Revenue187.34M
Gross Profit141.98M
Operating Income-3.29M
Pretax Income-9.96M
Net Income-9.96M
EBITDA6.08M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was 7.19M and capital expenditures -1.65M, giving a free cash flow of 5.54M billion.
Operating Cash Flow7.19M
Free Cash Flow5.54M
Free Cash Flow per Share0.12
Dividends & Yields
AxoGen pays an annual dividend of $1, resulting in a dividend yield of ―
Dividend Per Share$1
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change19.69%
50-Day Moving Average14.55
200-Day Moving Average15.11
Relative Strength Index (RSI)66.39
Average Volume (3m)1.18M
Important Dates
AxoGen upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend DateJan 27, 2010
Financial Position
AxoGen as a current ratio of 3.24, with Debt / Equity ratio of 60.73%
Current Ratio3.24
Quick Ratio2.16
Debt to Market Cap0.07
Net Debt to EBITDA6.77
Interest Coverage Ratio-0.40
Taxes
In the past 12 months, AxoGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AxoGen EV to EBITDA ratio is 126.75, with an EV/FCF ratio of 70.05K.
EV to Sales4.11
EV to EBITDA126.75
EV to Free Cash Flow70.05K
EV to Operating Cash Flow169.90
Balance Sheet
AxoGen has $35.92M in cash and marketable securities with $68.19M in debt, giving a net cash position of -$32.27M billion.
Cash & Marketable Securities$35.92M
Total Debt$68.19M
Net Cash-$32.27M
Net Cash Per Share-$0.70
Tangible Book Value Per Share$2.22
Margins
Gross margin is 74.27%, with operating margin of -1.75%, and net profit margin of -5.32%.
Gross Margin74.27%
Operating Margin-1.75%
Pretax Margin-5.32%
Net Profit Margin-5.32%
EBITDA Margin3.24%
EBIT Margin-0.94%
Analyst Forecast
The average price target for AxoGen is $23.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$23.29
Price Target Upside35.41% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast17.17%
EPS Growth Forecast72.68%